The NHLBI SBIR/STTR Program, NHLBI

About the NHLBI SBIR/STTR Program

The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs are engines of innovation for developing and commercializing novel technologies and products to promote the prevention, diagnosis, and treatment of heart, lung, blood, and sleep diseases and disorders. The NHLBI provides grant and contract funding opportunities to support small businesses performing research and development on technologies related to the mission of NHLBI.

The links on the left will assist you in finding funding opportunities, resources, and help related to the NHLBI SBIR/STTR program.

What's New?

2013 Annual Contract Solicitation published: The NHLBI has nine topics in this year's solicitation, ranging from sleep to transfusion medicine and from MRI-compatible devices to nanotechnology. You can see all of our topics and the details of how to apply on our Annual Contracts page. The submission date is November 13, 2012.

2012 SBIR/STTR National Conference: Please join us for this year's SBIR/STTR National Conference image of external link icon

November 13-15 in Portland, OR. We will be available during the one-on-one sessions to offer advice about the NHLBI SBIR/STTR programs, funding opportunities, and resources.

Intellectual Property Assessment Tool for the USPTO: The United States Patent and Trademark Office (USPTO) has unveiled an Intellectual Property Awareness Assessment Tool, a web-based tool designed to assess intellectual property (IP) knowledge and provide personalized training resources for small and medium sized enterprises (SMEs) and inventors. If you’d care to test and/or increase your IP awareness, check out the Intellectual Property Assessment Tool. image of external link icon

You can find other resources to help your small business on our Resources page.

SBIR-Technology Transfer for Cerclage Mitral Valve Annuloplasty: Receive SBIR funding and a non-exclusive research and development license to further develop this NHLBI intramural technology. Learn more...

Congratulations to Advanced Circulatory Systems for receiving a 2012 Tibbetts Award, an honor given to outstanding small businesses. Learn more about this innovative company.

SBIR Phase IIB Bridge Awards: The NHLBI is soliciting Phase IIB applications to accelerate the commercialization of technologies for heart, lung, blood, and sleep disorders and diseases. Learn more...

SBIR/STTR Omnibus Grant Solicitations Published: The 2012 NIH SBIR and STTR Omnibus Grant Solicitations have been published.

NIH Start-up Exclusive Licensing: NIH has developed a new short-term exclusive Start-Up Evaluation License Agreement (Start-up EELA) and a Start-up Exclusive Commercial License Agreement (Start-up ECLA) to facilitate licensing of intramural NIH and Food and Drug Administrative (FDA) inventions to start-up companies. Learn more.

Commercialize NIH Technologies: The NHLBI is seeking SBIR applications for projects to transfer technologies out of the NHLBI intramural research labs into the private sector that address mechanisms, diseases, or disorders within the NHLBI mission. Read more.

Last Updated August 2012

Skip to content past banner and navigation links U.S. Department of Health & Human Services National Institutes of Health Contact Us Get Email Alerts Font Size Accessible Search Form Advanced Search Search the NHLBI, use the drop down list to select: the entire site, the Health Topics section only, or the News and Resources section. NHLBI Entire Site NHLBI Entire Site1 Health Topics2 News & Resources3
Home » Funding and Research » SBIR » NHLBI SBIR/STTR Program

NHLBI SBIR/STTR OTAC HOME Funding opportunities Resources Get Help Contact us	The NHLBI SBIR/STTR Program About the NHLBI SBIR/STTR Program The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs are engines of innovation for developing and commercializing novel technologies and products to promote the prevention, diagnosis, and treatment of heart, lung, blood, and sleep diseases and disorders. The NHLBI provides grant and contract funding opportunities to support small businesses performing research and development on technologies related to the mission of NHLBI. The links on the left will assist you in finding funding opportunities, resources, and help related to the NHLBI SBIR/STTR program. What's New? 2013 Annual Contract Solicitation published: The NHLBI has nine topics in this year's solicitation, ranging from sleep to transfusion medicine and from MRI-compatible devices to nanotechnology. You can see all of our topics and the details of how to apply on our Annual Contracts page. The submission date is November 13, 2012. 2012 SBIR/STTR National Conference: Please join us for this year's SBIR/STTR National Conference November 13-15 in Portland, OR. We will be available during the one-on-one sessions to offer advice about the NHLBI SBIR/STTR programs, funding opportunities, and resources. *Intellectual Property Assessment Tool for the USPTO:* The United States Patent and Trademark Office (USPTO) has unveiled an Intellectual Property Awareness Assessment Tool, a web-based tool designed to assess intellectual property (IP) knowledge and provide personalized training resources for small and medium sized enterprises (SMEs) and inventors. If you’d care to test and/or increase your IP awareness, check out the Intellectual Property Assessment Tool. You can find other resources to help your small business on our Resources page. *SBIR-Technology Transfer for Cerclage Mitral Valve Annuloplasty:* Receive SBIR funding and a non-exclusive research and development license to further develop this NHLBI intramural technology. Learn more... *Congratulations to Advanced Circulatory Systems* for receiving a 2012 Tibbetts Award, an honor given to outstanding small businesses. Learn more about this innovative company. SBIR Phase IIB Bridge Awards: The NHLBI is soliciting Phase IIB applications to accelerate the commercialization of technologies for heart, lung, blood, and sleep disorders and diseases. Learn more... SBIR/STTR Omnibus Grant Solicitations Published: The 2012 NIH SBIR and STTR Omnibus Grant Solicitations have been published. NIH Start-up Exclusive Licensing: NIH has developed a new short-term exclusive Start-Up Evaluation License Agreement (Start-up EELA) and a Start-up Exclusive Commercial License Agreement (Start-up ECLA) to facilitate licensing of intramural NIH and Food and Drug Administrative (FDA) inventions to start-up companies. Learn more. Commercialize NIH Technologies: The NHLBI is seeking SBIR applications for projects to transfer technologies out of the NHLBI intramural research labs into the private sector that address mechanisms, diseases, or disorders within the NHLBI mission. Read more. Archives of What's New Last Updated August 2012	NHLBI Bridge Award Up to $1 million per year for three years to support the next stage of development for previously funded SBIR Phase II projects. Learn more. SBIR-TT Program Looking for high-quality technologies? Get funded to develop NHLBI intramural innovations. Learn more. Learn More Sign up to receive the latest NHLBI small business program news by using the NHLBI-SBIR subscriber page on the NIH LISTSERV Web site.